{"id":838611,"date":"2025-04-17T08:59:42","date_gmt":"2025-04-17T12:59:42","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/arcutis-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-6-2025\/"},"modified":"2025-04-17T08:59:42","modified_gmt":"2025-04-17T12:59:42","slug":"arcutis-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-6-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/arcutis-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-6-2025\/","title":{"rendered":"Arcutis to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">WESTLAKE VILLAGE, Calif., April  17, 2025  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9gkKWrxLJNS-McZcGow6BoKQYWxT5MYny38WGfSOLbvhiKtT5W4M7Bu4Gg00kFrIunKJcZULnFOdcaTE7fzR2tXvPOphkbF09L7EVFdNXzE=\" rel=\"nofollow\" target=\"_blank\">Arcutis Biotherapeutics, Inc.<\/a>\u00a0(Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that it will report first quarter 2025 financial results and provide a business update on Tuesday, May 6, 2025 after the U.S. financial markets close. The Company will also host a conference call and webcast the same day at 4:30 p.m. ET.<\/p>\n<p>A live webcast of the call and the presentation materials will be available on the \u201c<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9pIevKVs3QwuwlUqhUIRjjR4Lp6CR7PD0Mw6dGOsJrJUrqN0MxP7CMeYqjKkxHvjwkSlEwA7b5iTph_Zrlu1ntbwacCaJSJGXmtvTXvUqSQOmTksfMqaEw_yNo3ISmBAVNaQvRIuZb9blCMEexGThw==\" rel=\"nofollow\" target=\"_blank\">Events<\/a>\u201d section of The Company\u2019s website. An archived replay of the webcast will be available on the Arcutis investor website following the conference call.<\/p>\n<p>\n        <strong>About Arcutis<\/strong><br \/>\n        <br \/>Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is a commercial-stage medical dermatology company that champions meaningful innovation to address the urgent needs of individuals living with immune-mediated dermatological diseases and conditions. With a commitment to solving the most persistent patient challenges in dermatology, Arcutis has a growing portfolio including three FDA approved products that harness our unique dermatology development platform coupled with our dermatology expertise to build differentiated therapies against biologically validated targets. Arcutis\u2019 dermatology development platform includes a robust pipeline with multiple clinical programs for a range of inflammatory dermatological conditions including scalp and body psoriasis, atopic dermatitis, and alopecia areata. For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JFysRSaDClNIwObIFzaCifz62-VKBlIat3XVS847kl3SgyRX2fu3BrMTi1_J0KjDViMlNAhdTOdUsuqEMWL81g==\" rel=\"nofollow\" target=\"_blank\">www.arcutis.com<\/a>\u00a0or follow Arcutis on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jlAr-8ZSRl6jUEvrTCWPg6f4qySKH2a39W-O3oZaBqxpwc_RetCplgM7RDn1gMPnMAqDg7sXfSr2vLvjoNKhtb6IZtnknhOynyVD3Gnwo0maHwq7uolsxMKpna-G_a9E\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1AqymLQ0dwXkEi24LFzHuk5wpEc01_chlSwxUavHYH3OEKQzznH6YRF9hvXtUd9_AIyaSPzNafoqYvdfnLhfd4YuP98E8XTIC-oOkzf31ahr7VrbPJBPZm_-mCuDh1c68V9nygopDmhXlzEQkew-pA==\" rel=\"nofollow\" target=\"_blank\">Facebook<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=liK3isCPXBZZDV633lOxvwt8ayQvJja73nWJDWm_Yg12dOJsrKfdEi-Cng6y7AxUop9P3xY9bdqorlh_2CRVvNp43XZuSZk4uIjvIk2qxb0=\" rel=\"nofollow\" target=\"_blank\">Instagram<\/a>, and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7AkBdUXg2PLgTZozH7en9owLxLoEw1puL5YfIBE41UJvZMS-Vm47ek-u08xX7IX6gMI666JOdriTyFLcRSfHXg==\" rel=\"nofollow\" target=\"_blank\">X<\/a>.<\/p>\n<p>\n        <strong>Forward-Looking Statements<\/strong><br \/>\n        <br \/>This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. For example, statements contained in this press release regarding matters that are not historical facts are forward-looking statements. These statements are based on the Company\u2019s current beliefs and expectations and are subject to substantial known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from the information expressed or implied by these forward-looking statements. Risks and uncertainties that may cause our actual results to differ include risks inherent in our business, reimbursement and access to our products, the impact of competition and other important factors discussed in the \u201cRisk Factors\u201d section of our Form 10-K filed with the U.S. Securities and Exchange Commission (SEC) on February 25, 2025, as well as any subsequent filings with the SEC. Any forward-looking statements that the company makes in this press release are made pursuant to the Private Securities Litigation Reform Act of 1995, as amended, and speak only as of the date of this press release. Except as required by law, we undertake no obligation to revise or update information herein to reflect events or circumstances in the future, even if new information becomes available.<\/p>\n<p>\n        <strong>Contacts:<\/strong>\n      <\/p>\n<p>\n        <strong><br \/>\n          <em><br \/>\n            <u>Media<\/u><br \/>\n          <\/em><br \/>\n        <\/strong><br \/>\n        <br \/>Amanda Sheldon, Head of Corporate Communications<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ELDY3u3eTSW11ESJz86mY_JWP5GpwDUhVbgMLweVnBPQ5dUz-lAgozPUy3VMG7fYPPyOrdIfRkVxv2BD5GtSVRmpIb_XGShef7on_38kWX0=\" rel=\"nofollow\" target=\"_blank\">media@arcutis.com<\/a><\/p>\n<p>\n        <strong><br \/>\n          <em><br \/>\n            <u>Investors<\/u><br \/>\n          <\/em><br \/>\n        <\/strong><br \/>\n        <br \/>Latha Vairavan, Vice President, Finance and Corporate Controller<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WoXeDJCXPkWXD3QqXkzkl586mrZafxa4vrdWZUzIrom1rUGCZvbYkYsUTLTtgm2jyeCqknDywQjxidVzpCFhdA==\" rel=\"nofollow\" target=\"_blank\">ir@arcutis.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMzgxOSM2ODcwNzc5IzIxOTQwNTA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZTliMDZjODQtNmEyMi00OTEyLWI2NjMtMTM3MDA4NGM3NGE5LTEyMDU2MDMtMjAyNS0wNC0xNy1lbg==\/tiny\/Arcutis-Biotherapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WESTLAKE VILLAGE, Calif., April 17, 2025 (GLOBE NEWSWIRE) &#8212; Arcutis Biotherapeutics, Inc.\u00a0(Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that it will report first quarter 2025 financial results and provide a business update on Tuesday, May 6, 2025 after the U.S. financial markets close. The Company will also host a conference call and webcast the same day at 4:30 p.m. ET. A live webcast of the call and the presentation materials will be available on the \u201cEvents\u201d section of The Company\u2019s website. An archived replay of the webcast will be available on the Arcutis investor website following the conference call. About Arcutis Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is a commercial-stage medical dermatology company &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/arcutis-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-6-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Arcutis to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-838611","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Arcutis to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/arcutis-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-6-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Arcutis to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WESTLAKE VILLAGE, Calif., April 17, 2025 (GLOBE NEWSWIRE) &#8212; Arcutis Biotherapeutics, Inc.\u00a0(Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that it will report first quarter 2025 financial results and provide a business update on Tuesday, May 6, 2025 after the U.S. financial markets close. The Company will also host a conference call and webcast the same day at 4:30 p.m. ET. A live webcast of the call and the presentation materials will be available on the \u201cEvents\u201d section of The Company\u2019s website. An archived replay of the webcast will be available on the Arcutis investor website following the conference call. About Arcutis Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is a commercial-stage medical dermatology company &hellip; Continue reading &quot;Arcutis to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/arcutis-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-6-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-17T12:59:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMzgxOSM2ODcwNzc5IzIxOTQwNTA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arcutis-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-6-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arcutis-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-6-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Arcutis to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025\",\"datePublished\":\"2025-04-17T12:59:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arcutis-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-6-2025\\\/\"},\"wordCount\":486,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arcutis-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-6-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQyMzgxOSM2ODcwNzc5IzIxOTQwNTA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arcutis-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-6-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arcutis-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-6-2025\\\/\",\"name\":\"Arcutis to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arcutis-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-6-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arcutis-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-6-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQyMzgxOSM2ODcwNzc5IzIxOTQwNTA=\",\"datePublished\":\"2025-04-17T12:59:42+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arcutis-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-6-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arcutis-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-6-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arcutis-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-6-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQyMzgxOSM2ODcwNzc5IzIxOTQwNTA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQyMzgxOSM2ODcwNzc5IzIxOTQwNTA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arcutis-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-6-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Arcutis to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Arcutis to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/arcutis-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-6-2025\/","og_locale":"en_US","og_type":"article","og_title":"Arcutis to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025 - Market Newsdesk","og_description":"WESTLAKE VILLAGE, Calif., April 17, 2025 (GLOBE NEWSWIRE) &#8212; Arcutis Biotherapeutics, Inc.\u00a0(Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that it will report first quarter 2025 financial results and provide a business update on Tuesday, May 6, 2025 after the U.S. financial markets close. The Company will also host a conference call and webcast the same day at 4:30 p.m. ET. A live webcast of the call and the presentation materials will be available on the \u201cEvents\u201d section of The Company\u2019s website. An archived replay of the webcast will be available on the Arcutis investor website following the conference call. About Arcutis Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is a commercial-stage medical dermatology company &hellip; Continue reading \"Arcutis to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/arcutis-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-6-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-04-17T12:59:42+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMzgxOSM2ODcwNzc5IzIxOTQwNTA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arcutis-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-6-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arcutis-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-6-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Arcutis to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025","datePublished":"2025-04-17T12:59:42+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arcutis-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-6-2025\/"},"wordCount":486,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arcutis-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-6-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMzgxOSM2ODcwNzc5IzIxOTQwNTA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arcutis-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-6-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/arcutis-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-6-2025\/","name":"Arcutis to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arcutis-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-6-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arcutis-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-6-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMzgxOSM2ODcwNzc5IzIxOTQwNTA=","datePublished":"2025-04-17T12:59:42+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arcutis-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-6-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/arcutis-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-6-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arcutis-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-6-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMzgxOSM2ODcwNzc5IzIxOTQwNTA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMzgxOSM2ODcwNzc5IzIxOTQwNTA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arcutis-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-6-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Arcutis to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/838611","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=838611"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/838611\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=838611"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=838611"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=838611"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}